A4L Announces IBM Innovation Space Participation

TORONTO, ON – Sep. 22, 2016 – Yesterday at a gathering of IBM executives and Ontario government officials, Analytics 4 Life (A4L), a Toronto-based eHealth company, announced its participation in the new and first IBM Innovation Space. Earlier this year, the Ontario government partnering with the Ontario Centres of Excellence (OCE) and IBM committed $54 million to support the creation of innovation hubs across Ontario to help small- and medium-sized businesses fast-track the introduction of new technologies and global expansion.

As a flagship company in the program, A4L was one of the first ventures to occupy space in the Toronto-based technology centre. The new office space provides access to technical resources, including IBM Cloud, IBM Watson cognitive business technology, IBM SoftLayer, and the IBM Bluemix cloud development platform. This collaboration equips A4L with secure and scalable cloud infrastructure to support its machine intelligence platform, Agilytics™.

Founded in Kingston, ON, privately-funded A4L now has offices in Toronto and the Research Triangle Park in North Carolina. “A few years ago, a small group of scientists at A4L realized that by applying machine learning to the signals naturally generated by the body, they could identify disease states,” says Ian Shadforth, A4L’s Chief Technology Officer. “Now we are building cloud-based medical device products that leverage a world-class suite of IBM cloud services to rapidly achieve our product development goals.”

In May 2016, the company launched its multi-center Coronary Artery Disease Learning and Algorithm Development (CADLAD) clinical study that will enroll up to 2,500 subjects from up to 25 medical centers within the United States. Chief Medical Officer, Dr. William Sanders, says, “A4L is currently testing a system that safely records patient signals and wirelessly transmits these files to secure cloud storage that allows powerful computer analytics to access and analyze billions of data points in real time.” He added, “CorVista™ is an investigational device and has not been approved for commercial distribution.”

The IBM Innovation Space was developed through Ontario’s Jobs and Prosperity Fund, which is expected to create up to 2,600 jobs and generate $410 million in follow-on investment.About CorVista® System
CorVista is a non-invasive medical imaging system that is designed to acquire and process patient data and display results in a report accessible via a secure web portal. The system scans signals emitted by the body without radiation, exercise, or pharmacologic stress and wirelessly transmits the signal package to the cloud for processing and report generation. Physicians can interpret and use the results as part of an assessment of their patient. CorVista is an investigational device limited by federal law to investigational use. CorVista is not available for commercial distribution.

About Analytics 4 Life®
Analytics 4 Life is pioneering digital health using artificial intelligence to develop a completely new cardiac diagnostic modality. With an initial focus on coronary artery disease, heart failure, and pulmonary hypertension, Analytics 4 Life is advancing a novel, radiation-free, and exercise-free cardiac diagnostic platform aimed at improving existing care pathways. Analytics 4 Life is based in Toronto with U.S. headquarters in Washington, D.C.

Contacts

CorVista Health
Chris Bing Ernst
(415) 710-9445
[email protected]

SOURCE: PR Newswire

CorVista provides actionable cardiac diagnostics at the point of care by applying advanced machine learning for more rapid and accurate diagnosis of cardiac disease.
Find Us
United States
3 Bethesda Metro Center,
Suite 700
Bethesda, MD 20814
(833) 267-8478
CorVista Health 2024 | All rights reserved
Privacy PolicyTerms of Use